Cord Blood Registry® (CBR®), the world’s largest and most experienced cord blood stem cell bank, today announced that it has released a total of five stem cell samples in the first quarter of the year for transplant or infusion. Three of the cases are individuals who will require their own cord blood stem cells for autologous infusions for cerebral palsy, type I diabetes, and a rare autoimmune disorder related to autism. The additional two samples were released for use by a sibling in each family: one to treat acute myeloid leukemia and the other to treat a serious blood disease,...